Company Filing History:
Years Active: 2014
Title: Miho Shukuri: Innovator in Isotope Labeled Compounds
Introduction
Miho Shukuri is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of isotope-labeled compounds. His work has implications for advanced imaging techniques in medical diagnostics.
Latest Patents
Miho Shukuri holds a patent for "Isotope labeled 2-arylpropionic acid compounds and process for production of same, and molecular probe for positron emission tomography and method for imaging of cyclooxygenase and the like using same." This patent discloses labeled NSAID compounds that can be produced quickly and are suitable for positron emission tomography (PET) methods. These compounds enable the imaging of cyclooxygenase-2, which is crucial for various medical applications.
Career Highlights
Miho Shukuri is associated with Riken Corporation, a leading research institution in Japan. His innovative work in the field of isotope-labeled compounds has positioned him as a key figure in medicinal chemistry. His research focuses on creating compounds that enhance imaging techniques, thereby improving diagnostic capabilities.
Collaborations
Miho Shukuri has collaborated with notable colleagues, including Misato Takashima and Miki Goto. These collaborations have furthered the development of his patented technologies and contributed to advancements in the field.
Conclusion
Miho Shukuri's contributions to the field of isotope-labeled compounds demonstrate his commitment to advancing medical imaging technologies. His innovative work continues to impact the landscape of medicinal chemistry and diagnostic imaging.